Method for producing dispersible sterol and stanol compounds
    5.
    发明授权
    Method for producing dispersible sterol and stanol compounds 有权
    分散性甾醇和甾烷醇化合物的制备方法

    公开(公告)号:US06242001B1

    公开(公告)日:2001-06-05

    申请号:US09200623

    申请日:1998-11-30

    IPC分类号: A61K914

    摘要: A method for preparing sterol/stanol and sterol/stanol ester compositions with improved dispersibility is provided by co-melting the sterol/stanol and/or sterol/stanol ester with highly branched hydrocarbons and then grinding the resulting product. A method for preparing the compounds is also disclosed. The ground compound is suitable for formulating into orally administered products suitable for control of blood serum cholesterol.

    摘要翻译: 通过将甾醇/甾烷醇和/或甾醇/甾烷醇酯与高度支化的烃共熔,然后研磨所得产物,提供了具有改进的分散性的固醇/甾烷醇和甾醇/甾烷醇酯组合物的制备方法。 还公开了一种制备该化合物的方法。 地面化合物适用于配制成适合于控制血清胆固醇的口服制剂。

    Method for producing dispersible sterol and stanol compounds
    7.
    发明授权
    Method for producing dispersible sterol and stanol compounds 有权
    分散性甾醇和甾烷醇化合物的制备方法

    公开(公告)号:US06387411B2

    公开(公告)日:2002-05-14

    申请号:US09826072

    申请日:2001-04-04

    IPC分类号: A61K914

    摘要: A method for preparing sterol/stanol and sterol/stanol ester compositions with improved dispersibility is provided by co-melting the sterol/stanol and/or sterol/stanol ester with highly branched hydrocarbons and then grinding the resulting product. A method for preparing the compounds is also disclosed. The ground compound is suitable for formulating into orally administered products suitable for control of blood serum cholesterol.

    摘要翻译: 通过将甾醇/甾烷醇和/或甾醇/甾烷醇酯与高度支化的烃共熔,然后研磨所得产物,提供了具有改进的分散性的固醇/甾烷醇和甾醇/甾烷醇酯组合物的制备方法。 还公开了一种制备该化合物的方法。 地面化合物适用于配制成适合于控制血清胆固醇的口服制剂。

    Aliphatic or fatty acid esters as a solventless carrier for
pharmaceuticals
    8.
    发明授权
    Aliphatic or fatty acid esters as a solventless carrier for pharmaceuticals 失效
    作为药物的无溶剂载体的脂肪族或脂肪酸酯

    公开(公告)号:US5405617A

    公开(公告)日:1995-04-11

    申请号:US790613

    申请日:1991-11-07

    IPC分类号: A61K9/16

    CPC分类号: A61K9/1617

    摘要: A physicochemically stable pharmaceutical matrix composition is provided comprising: a pharmaceutical active and a water insoluble aliphatic or fatty acid ester, preferably stearyl stearate; a taste mask carrier for pharmaceutical actives comprising a taste masking effective amount of an aliphatic or fatty acid ester; and a method for preparing a pharmaceutical matrix without the use of organic and/or volatile solvents comprising the steps of: melting an aliphatic or fatty acid ester; admixing at least one pharmaceutical active with the molten aliphatic or fatty acid ester; and solidifying the admixture to produce a pharmaceutical matrix composition. The matrix is composed of an aliphatic, or fatty acid, ester that has a low melting point (50.degree.-100.degree. C.) and the melt exhibits: low viscosity, recongeals rapidly when cooled, does not exhibit polymorphism, and has good mold release properties.

    摘要翻译: 提供了一种物理化学稳定的药物基质组合物,其包含:药物活性物质和水不溶性脂肪酸或脂肪酸酯,优选硬脂酸硬脂酯; 用于药物活性物质的掩味载体,其包含掩味有效量的脂族或脂肪酸酯; 以及不使用有机和/或挥发性溶剂制备药物基质的方法,包括以下步骤:使脂族或脂肪酸酯熔融; 将至少一种药物活性物质与熔融的脂族或脂肪酸酯混合; 并固化该混合物以产生药物基质组合物。 该基质由具有低熔点(50℃-100℃)的脂肪酸或脂肪酸酯组成,熔体表现出:粘度低,冷却时快速组合,不显示多晶型,并具有良好的模具 释放属性。